5. Conclusions
diabetes
TYPE 1 DIABETES, DIABETES
The appropriate interpretation of trend arrows has the potential to maximize glycemic outcomes and improve engagement with diabetes self-management in patients with type 1 diabetes using CGM devices. We conducted a head-to-head comparison between two different algorithms for trend-informed bolus adjustments, and we have shown that the Ziegler algorithm is safe and provides better glucose control and variability than the DirectNet/JDRF, as measured by CGM over two weeks, especially in patients treated with CSII. Further research is needed to clarify whether these benefits are maintained in the long term and may also apply to type 2 patients on intensive insulin treatments or to pediatric patients.